December 22, 2014 5:40 AM ET

Pharmaceuticals

Company Overview of Nura Inc.

Company Overview

Nura, Inc., a development stage biotechnology company, engages in the development and discovery of therapeutics for behavioral disorders and neurodegenerative diseases. The company focuses on behavioral and neurodegenerative diseases with particular emphasis on G Protein-coupled receptor (GPCR) and phosphodiesterase (PDE) targets expressed in the brain. Its programs include schizophrenia, pain, and attention-deficit hyperactivity disorder. The company was founded in 2003 and is based in Seattle, Washington. As of September 7, 2006, Nura, Inc. operates as a subsidiary of Omeros Corporation.

1124 Columbia Street

Seattle, WA 98104

United States

Founded in 2003

Phone:

206-344-2100

Fax:

206-344-2101

Key Executives for Nura Inc.

Chief Executive Officer and President
Co-founder
Age: 67
Chief Financial Officer
Age: 54
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Sound Pharmaceuticals, Inc. United States
Danbury Pharmacal Inc. United States
Trutek Corp. United States
Tragara Pharmaceuticals, Inc. United States
LQ3 Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nura Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.